What does CUSIP 83558L204 represent in this 13F holders report?

CUSIP 83558L204 is the security identifier for SNOA - SONOMA PHARMACEUTICALS INC - COM NEW used to aggregate holder disclosures.

How many institutions held SNOA - SONOMA PHARMACEUTICALS INC - COM NEW in Q1 2020?

7 institutional investors reported SNOA - SONOMA PHARMACEUTICALS INC - COM NEW for Q1 2020. Use the holders table for investor-level position and value details.

SONOMA PHARMACEUTICALS INC - COM NEW (SNOA)

CUSIP: 83558L204

Q1 2020 13F Holders as of 31 Mar 2020

Security type / class: Equity / COM NEW
Total 13F shares: 127,569
Total 13F value: $625,010
Share change: +420
SEC-reported price per share: $4.94
Number of holders: 7
Value change: +$1,687
Number of buys: 2
Number of sells: 3

Security key

83558L204

Report period

Q1 2020

Institutions

Top holders

SNOA full security history Ownership snapshot Full 13F holder table Sonoma Pharmaceuticals, Inc. SEC filings Sonoma Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SNOA - SONOMA PHARMACEUTICALS INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BARD ASSOCIATES INC

Disclosed value leader

BARD ASSOCIATES INC

Comparable rows

0/9

Latest evidence

31 Dec 2019

13F Highest disclosed value: $262,000 9 rows are not safely comparable across share classes. Showing 1-6 of 9 holder rows.

Quick read

BARD ASSOCIATES INC has the largest disclosed position value at $262K.

0 of 9 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BARD ASSOCIATES INC's linked filing trail.

Disclosed position value Top 5

BARD ASSOCIATES INC $262K

RENAISSANCE TECHNOLOGIES LLC $256K

BlackRock Finance, Inc. $15K

UBS Group AG $12K

ACADIAN ASSET MANAGEMENT LLC $6K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 9 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BARD ASSOCIATES INC	13F Company 13F	— denominator unverified	$262,000 60,240 shares	—	31 Dec 2019
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	— denominator unverified	$256,000 58,709 shares	—	31 Dec 2019
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$15,000 3,444 shares	—	31 Dec 2019
UBS Group AG	13F Company 13F	— denominator unverified	$12,000 2,703 shares	—	31 Dec 2019
ACADIAN ASSET MANAGEMENT LLC	13F Company 13F	— denominator unverified	$6,000 1,551 shares	—	31 Dec 2019
DEUTSCHE BANK AG\	13F Company 13F	— denominator unverified	$2,000 500 shares	—	31 Dec 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

127,569

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Holder diff

Investor	Q1 2020 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q1 2020 value	Q1 2020 value	Value change	Value Chg %